NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 86 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2015. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,000 | 0.0% | 7,374 | +12.2% | 0.00% | – |
| Q2 2016 | $4,000 | -99.8% | 6,570 | -99.5% | 0.00% | – |
| Q1 2016 | $1,976,000 | -52.3% | 1,353,312 | +4.5% | 0.00% | -100.0% |
| Q4 2015 | $4,143,000 | -46.0% | 1,294,831 | +5.5% | 0.00% | -50.0% |
| Q3 2015 | $7,674,000 | -36.7% | 1,227,807 | +0.6% | 0.00% | -33.3% |
| Q2 2015 | $12,124,000 | +37.1% | 1,220,960 | +1.7% | 0.00% | +50.0% |
| Q1 2015 | $8,844,000 | +54.5% | 1,200,051 | +12.2% | 0.00% | +100.0% |
| Q4 2014 | $5,725,000 | +33.0% | 1,070,030 | +25.1% | 0.00% | 0.0% |
| Q3 2014 | $4,303,000 | -26.8% | 855,537 | -2.4% | 0.00% | -50.0% |
| Q2 2014 | $5,882,000 | +829.2% | 876,583 | +903.4% | 0.00% | – |
| Q1 2014 | $633,000 | +119.0% | 87,364 | +13.8% | 0.00% | – |
| Q4 2013 | $289,000 | +42.4% | 76,771 | +27.4% | 0.00% | – |
| Q3 2013 | $203,000 | +9.1% | 60,273 | +8.5% | 0.00% | – |
| Q2 2013 | $186,000 | – | 55,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 25,915,937 | $14,062,000 | 0.57% |
| Family Management Corp | 105,975 | $58,000 | 0.03% |
| HYMAN CHARLES D | 249,625 | $135,000 | 0.02% |
| Montecito Bank & Trust | 75,717 | $41,000 | 0.02% |
| WEDBUSH SECURITIES INC | 162,200 | $88,000 | 0.01% |
| Cutler Group LLC / CA | 9,600 | $105,000 | 0.01% |
| WHALEROCK POINT PARTNERS, LLC | 15,000 | $8,000 | 0.00% |
| TELEMUS CAPITAL, LLC | 32,401 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 15,504 | $8,000 | 0.00% |
| Creative Planning | 413,500 | $224,000 | 0.00% |